Methods
| The ProVac Approach |
 |
Andrus, J. et al. (2007). A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: Paho’s Provac Initiative. Public Health Rep, 122, 6, 811-816. Download |
| ProVac Models |
|
Clark, A. et al. (2013). TRIVAC decision support model for evaluating cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination. Vaccine, 31(Suppl 3), C19-29. doi:10.1016/j.vaccine.2013.05.04. Download |
|
Castañeda-Orjuela, C. et al. (2013). Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization. Vaccine, 31(Suppl 3), C72-9. doi: 10.1016/j.vaccine.2013.05.038. Download |
| ProVac Methods Guidance |
|
Sinha, A., Augustovski, F., Alcarez, A. & García Martí, S. (2013). Perspectives on the challenge of Streptococcus pneumoniae disease burden estimation for national policymakers in Latin America and the Caribbean: From theory to practice. Vaccine, 31(Suppl 3), C30-2. doi: 10.1016/j.vaccine.2013.05.052. Download |
|
Sartori, A.M.C, Novaes, C.G., de Soárez, P.C., Toscano, C.M. & Novaes, H.M.D. (2013). Estimating health service utilization for treatment of pneumococcal disease: the case of Brazil. Vaccine, 31(Suppl 3),63-71. doi: 10.1016/j.vaccine.2013.05.029. Download |
This post is also available in:
French Spanish
